NANOX RELEASE TECHNOLOGY
About
Nanox is a fully integrated nano-biotechnology company dedicated to the research, development, testing and commercialization of advanced nano-pharmaceutical drugs — a true one-stop-shop built on four proprietary platforms: a) liposomes (Base of Anfonax / Anfotar and Irinax) b) nanoparticles (Base of Paclinax); c) microspheres (Base of Leupronax / Octreonax))and nanomicelles (nobel technology for delivery of active ingredients ). Behind its first proprietary product on the market lie more than ten years of work in R&D and regulatory management. While its commercial focus today is on the human pharmaceutical industry, these four platforms have potential applications in other industries —such as agrochemicals, cosmetics, animal medicines and nutritional food — extending the reach of the Company's technology beyond its current use.
Areas of activity
Life Science Domain
Pharma
Research
Representatives
CEO NANOX RELEASE
NANOX RELEASE TECHNOLOGY